Magnolia Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Buy |
9,999
+7,231
| +261% | +$1.34M | 0.47% | 54 |
|
|
2025
Q1 | $580K | Sell |
2,768
-1,266
| -31% | -$265K | 0.16% | 145 |
|
|
2024
Q4 | $717K | Buy |
+4,034
| New | +$717K | 0.19% | 126 |
|
|
2024
Q2 | – | Sell |
-4,885
| Closed | -$813K | – | 122 |
|
|
2024
Q1 | $813K | Buy |
4,885
+1,441
| +42% | +$240K | 0.68% | 45 |
|
|
2023
Q4 | $568K | Sell |
3,444
-148
| -4% | -$24.4K | 0.41% | 64 |
|
|
2023
Q3 | $510K | Buy |
3,592
+48
| +1% | +$6.81K | 0.49% | 46 |
|
|
2023
Q2 | $477K | Sell |
3,544
-3
| -0.1% | -$404 | 0.24% | 88 |
|
|
2023
Q1 | $565K | Buy |
3,547
+438
| +14% | +$69.8K | 0.29% | 83 |
|
|
2022
Q4 | $502K | Buy |
+3,109
| New | +$502K | 0.33% | 82 |
|
|
2022
Q3 | – | Sell |
-1,316
| Closed | -$201K | – | 126 |
|
|
2022
Q2 | $201K | Sell |
1,316
-477
| -27% | -$72.9K | 0.18% | 114 |
|
|
2022
Q1 | $291K | Sell |
1,793
-206
| -10% | -$33.4K | 0.11% | 139 |
|
|
2021
Q4 | $271K | Sell |
1,999
-23
| -1% | -$3.12K | 0.08% | 162 |
|
|
2021
Q3 | $218K | Buy |
+2,022
| New | +$218K | 0.08% | 169 |
|
|
2021
Q2 | – | Sell |
-2,057
| Closed | -$223K | – | 143 |
|
|
2021
Q1 | $223K | Buy |
+2,057
| New | +$223K | 0.44% | 68 |
|